nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS1—malignant glioma	0.477	0.636	CbGaD
Bismuth Subsalicylate—PTGS2—malignant glioma	0.273	0.364	CbGaD
Bismuth Subsalicylate—TF—choroid plexus—malignant glioma	0.0419	0.357	CbGeAlD
Bismuth Subsalicylate—TF—pons—malignant glioma	0.0149	0.127	CbGeAlD
Bismuth Subsalicylate—TF—vertebral column—malignant glioma	0.0148	0.126	CbGeAlD
Bismuth Subsalicylate—TF—blood vessel—malignant glioma	0.00607	0.0518	CbGeAlD
Bismuth Subsalicylate—TF—embryo—malignant glioma	0.00362	0.0309	CbGeAlD
Bismuth Subsalicylate—TF—brainstem—malignant glioma	0.00332	0.0283	CbGeAlD
Bismuth Subsalicylate—TF—retina—malignant glioma	0.0032	0.0273	CbGeAlD
Bismuth Subsalicylate—TF—telencephalon—malignant glioma	0.00295	0.0251	CbGeAlD
Bismuth Subsalicylate—TF—medulla oblongata—malignant glioma	0.00232	0.0197	CbGeAlD
Bismuth Subsalicylate—TF—midbrain—malignant glioma	0.00212	0.018	CbGeAlD
Bismuth Subsalicylate—TF—spinal cord—malignant glioma	0.00206	0.0176	CbGeAlD
Bismuth Subsalicylate—PTGS1—endothelium—malignant glioma	0.00195	0.0166	CbGeAlD
Bismuth Subsalicylate—PTGS2—endothelium—malignant glioma	0.00187	0.0159	CbGeAlD
Bismuth Subsalicylate—PTGS1—blood vessel—malignant glioma	0.0018	0.0153	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood vessel—malignant glioma	0.00172	0.0147	CbGeAlD
Bismuth Subsalicylate—TF—central nervous system—malignant glioma	0.00168	0.0143	CbGeAlD
Bismuth Subsalicylate—TF—cerebellum—malignant glioma	0.00164	0.014	CbGeAlD
Bismuth Subsalicylate—Burning sensation—Carmustine—malignant glioma	0.00134	0.0607	CcSEcCtD
Bismuth Subsalicylate—TF—brain—malignant glioma	0.00133	0.0113	CbGeAlD
Bismuth Subsalicylate—Lung disorder—Temozolomide—malignant glioma	0.00127	0.0576	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Carmustine—malignant glioma	0.00106	0.0484	CcSEcCtD
Bismuth Subsalicylate—PTGS2—embryo—malignant glioma	0.00103	0.00875	CbGeAlD
Bismuth Subsalicylate—Hearing impaired—Temozolomide—malignant glioma	0.000943	0.0428	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Carmustine—malignant glioma	0.000887	0.0403	CcSEcCtD
Bismuth Subsalicylate—PTGS1—telencephalon—malignant glioma	0.000874	0.00745	CbGeAlD
Bismuth Subsalicylate—Skin exfoliation—Temozolomide—malignant glioma	0.000857	0.0389	CcSEcCtD
Bismuth Subsalicylate—PTGS2—telencephalon—malignant glioma	0.000835	0.00712	CbGeAlD
Bismuth Subsalicylate—Phlebitis—Carmustine—malignant glioma	0.000783	0.0356	CcSEcCtD
Bismuth Subsalicylate—Deafness—Temozolomide—malignant glioma	0.000729	0.0331	CcSEcCtD
Bismuth Subsalicylate—ALB—brain—malignant glioma	0.000692	0.0059	CbGeAlD
Bismuth Subsalicylate—Hyponatraemia—Carmustine—malignant glioma	0.000677	0.0308	CcSEcCtD
Bismuth Subsalicylate—PTGS2—medulla oblongata—malignant glioma	0.000656	0.00559	CbGeAlD
Bismuth Subsalicylate—PTGS1—spinal cord—malignant glioma	0.000612	0.00522	CbGeAlD
Bismuth Subsalicylate—PTGS2—midbrain—malignant glioma	0.0006	0.00511	CbGeAlD
Bismuth Subsalicylate—PTGS2—spinal cord—malignant glioma	0.000585	0.00499	CbGeAlD
Bismuth Subsalicylate—Weight increased—Temozolomide—malignant glioma	0.000513	0.0233	CcSEcCtD
Bismuth Subsalicylate—PTGS1—central nervous system—malignant glioma	0.000497	0.00423	CbGeAlD
Bismuth Subsalicylate—PTGS2—central nervous system—malignant glioma	0.000475	0.00405	CbGeAlD
Bismuth Subsalicylate—Hallucination—Carmustine—malignant glioma	0.000464	0.0211	CcSEcCtD
Bismuth Subsalicylate—PTGS2—cerebellum—malignant glioma	0.000464	0.00395	CbGeAlD
Bismuth Subsalicylate—Hepatitis—Temozolomide—malignant glioma	0.000451	0.0205	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Temozolomide—malignant glioma	0.000449	0.0204	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Temozolomide—malignant glioma	0.000426	0.0194	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Temozolomide—malignant glioma	0.00042	0.0191	CcSEcCtD
Bismuth Subsalicylate—Erythema—Carmustine—malignant glioma	0.000406	0.0184	CcSEcCtD
Bismuth Subsalicylate—PTGS1—brain—malignant glioma	0.000394	0.00336	CbGeAlD
Bismuth Subsalicylate—Erythema—Temozolomide—malignant glioma	0.000393	0.0178	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Temozolomide—malignant glioma	0.000384	0.0175	CcSEcCtD
Bismuth Subsalicylate—PTGS2—brain—malignant glioma	0.000377	0.00321	CbGeAlD
Bismuth Subsalicylate—Confusional state—Carmustine—malignant glioma	0.000334	0.0152	CcSEcCtD
Bismuth Subsalicylate—Oedema—Carmustine—malignant glioma	0.000331	0.0151	CcSEcCtD
Bismuth Subsalicylate—Infection—Carmustine—malignant glioma	0.000329	0.015	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Temozolomide—malignant glioma	0.000323	0.0147	CcSEcCtD
Bismuth Subsalicylate—Oedema—Temozolomide—malignant glioma	0.00032	0.0146	CcSEcCtD
Bismuth Subsalicylate—Infection—Temozolomide—malignant glioma	0.000318	0.0145	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Carmustine—malignant glioma	0.000316	0.0144	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Temozolomide—malignant glioma	0.000305	0.0139	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Carmustine—malignant glioma	0.000295	0.0134	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Carmustine—malignant glioma	0.000288	0.0131	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Temozolomide—malignant glioma	0.000285	0.0129	CcSEcCtD
Bismuth Subsalicylate—Pain—Carmustine—malignant glioma	0.000283	0.0129	CcSEcCtD
Bismuth Subsalicylate—Constipation—Carmustine—malignant glioma	0.000283	0.0129	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Temozolomide—malignant glioma	0.000282	0.0128	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Temozolomide—malignant glioma	0.000278	0.0126	CcSEcCtD
Bismuth Subsalicylate—Constipation—Temozolomide—malignant glioma	0.000274	0.0124	CcSEcCtD
Bismuth Subsalicylate—Pain—Temozolomide—malignant glioma	0.000274	0.0124	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Carmustine—malignant glioma	0.000273	0.0124	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Temozolomide—malignant glioma	0.000264	0.012	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Carmustine—malignant glioma	0.000262	0.0119	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Temozolomide—malignant glioma	0.000254	0.0116	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Temozolomide—malignant glioma	0.000253	0.0115	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Carmustine—malignant glioma	0.000227	0.0103	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Temozolomide—malignant glioma	0.000227	0.0103	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Carmustine—malignant glioma	0.000219	0.00996	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Temozolomide—malignant glioma	0.000219	0.00996	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Temozolomide—malignant glioma	0.000212	0.00962	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Carmustine—malignant glioma	0.000211	0.00957	CcSEcCtD
Bismuth Subsalicylate—Rash—Carmustine—malignant glioma	0.000209	0.00949	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Carmustine—malignant glioma	0.000209	0.00949	CcSEcCtD
Bismuth Subsalicylate—Headache—Carmustine—malignant glioma	0.000208	0.00943	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Temozolomide—malignant glioma	0.000204	0.00925	CcSEcCtD
Bismuth Subsalicylate—Rash—Temozolomide—malignant glioma	0.000202	0.00917	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Temozolomide—malignant glioma	0.000202	0.00917	CcSEcCtD
Bismuth Subsalicylate—Headache—Temozolomide—malignant glioma	0.000201	0.00912	CcSEcCtD
Bismuth Subsalicylate—Nausea—Carmustine—malignant glioma	0.000197	0.00894	CcSEcCtD
Bismuth Subsalicylate—Nausea—Temozolomide—malignant glioma	0.00019	0.00864	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.52e-05	0.000857	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—RAF1—malignant glioma	9.38e-05	0.000845	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—malignant glioma	9.07e-05	0.000817	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL2—malignant glioma	9.03e-05	0.000814	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	8.9e-05	0.000802	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RTEL1—malignant glioma	8.84e-05	0.000796	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	8.75e-05	0.000788	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ATP1B2—malignant glioma	8.67e-05	0.000781	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	8.43e-05	0.000759	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—VEGFA—malignant glioma	8.26e-05	0.000744	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	8.14e-05	0.000733	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	8.09e-05	0.000728	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	8.08e-05	0.000727	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—COX8A—malignant glioma	7.91e-05	0.000712	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	7.89e-05	0.000711	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	7.89e-05	0.000711	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	7.82e-05	0.000704	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.81e-05	0.000703	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	7.8e-05	0.000702	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	7.74e-05	0.000697	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.56e-05	0.000681	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	7.42e-05	0.000669	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ANGPT2—malignant glioma	7.38e-05	0.000665	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	7.34e-05	0.000661	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	7.33e-05	0.00066	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	7.2e-05	0.000649	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	7.2e-05	0.000648	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	7.04e-05	0.000634	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	7.03e-05	0.000633	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—KRAS—malignant glioma	7.02e-05	0.000633	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL2—malignant glioma	7.02e-05	0.000632	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7e-05	0.000631	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	6.78e-05	0.000611	CbGpPWpGaD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	6.78e-05	0.00061	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	6.73e-05	0.000606	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ASMT—malignant glioma	6.72e-05	0.000605	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6.7e-05	0.000604	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	6.65e-05	0.000599	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	6.64e-05	0.000598	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—malignant glioma	6.58e-05	0.000593	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—malignant glioma	6.58e-05	0.000593	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.57e-05	0.000592	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	6.46e-05	0.000582	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PIK3CA—malignant glioma	6.45e-05	0.000581	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HIST1H3B—malignant glioma	6.39e-05	0.000576	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MYB—malignant glioma	6.33e-05	0.00057	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCAN—malignant glioma	6.32e-05	0.000569	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.32e-05	0.000569	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—COX8A—malignant glioma	6.28e-05	0.000565	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	6.27e-05	0.000565	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—malignant glioma	6.24e-05	0.000562	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.11e-05	0.000551	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BCAN—malignant glioma	5.99e-05	0.00054	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—malignant glioma	5.8e-05	0.000522	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.71e-05	0.000514	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	5.66e-05	0.000509	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.61e-05	0.000505	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MYC—malignant glioma	5.49e-05	0.000494	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.42e-05	0.000488	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—DTX1—malignant glioma	5.42e-05	0.000488	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	5.37e-05	0.000483	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.34e-05	0.000481	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ASMT—malignant glioma	5.34e-05	0.000481	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.32e-05	0.000479	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—AKT1—malignant glioma	5.27e-05	0.000475	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.27e-05	0.000474	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—malignant glioma	5.23e-05	0.000471	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.22e-05	0.00047	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—malignant glioma	5.11e-05	0.00046	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	5.1e-05	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	5.1e-05	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—IDH2—malignant glioma	5.09e-05	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—COX8A—malignant glioma	5.08e-05	0.000457	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCAN—malignant glioma	5.02e-05	0.000452	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—H3F3A—malignant glioma	4.94e-05	0.000445	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	4.88e-05	0.00044	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	4.83e-05	0.000435	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.8e-05	0.000433	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2B6—malignant glioma	4.79e-05	0.000431	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.78e-05	0.00043	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.54e-05	0.000409	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—malignant glioma	4.5e-05	0.000406	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.49e-05	0.000404	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	4.47e-05	0.000402	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—IDH1—malignant glioma	4.38e-05	0.000395	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ASMT—malignant glioma	4.32e-05	0.000389	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	4.32e-05	0.000389	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	4.29e-05	0.000387	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HEY2—malignant glioma	4.25e-05	0.000383	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SPHK1—malignant glioma	4.24e-05	0.000382	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.22e-05	0.00038	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2C18—malignant glioma	4.15e-05	0.000374	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IDH1—malignant glioma	4.15e-05	0.000374	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KNG1—malignant glioma	4.07e-05	0.000366	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCAN—malignant glioma	4.06e-05	0.000366	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.06e-05	0.000365	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—IDH2—malignant glioma	4.04e-05	0.000364	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNA2—malignant glioma	3.99e-05	0.000359	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.96e-05	0.000357	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HEY1—malignant glioma	3.94e-05	0.000355	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.92e-05	0.000353	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	3.83e-05	0.000345	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIST1H3B—malignant glioma	3.82e-05	0.000344	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.81e-05	0.000343	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2B6—malignant glioma	3.8e-05	0.000342	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SOD1—malignant glioma	3.78e-05	0.00034	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.77e-05	0.00034	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.74e-05	0.000337	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.73e-05	0.000336	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.65e-05	0.000329	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.57e-05	0.000321	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JAG2—malignant glioma	3.49e-05	0.000314	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—IDH1—malignant glioma	3.48e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.48e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PTK2—malignant glioma	3.47e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.45e-05	0.000311	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.44e-05	0.00031	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	3.44e-05	0.000309	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SPHK1—malignant glioma	3.37e-05	0.000303	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTT1—malignant glioma	3.36e-05	0.000303	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2C18—malignant glioma	3.3e-05	0.000297	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH2—malignant glioma	3.27e-05	0.000295	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.17e-05	0.000285	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.14e-05	0.000282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.11e-05	0.00028	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.09e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2B6—malignant glioma	3.08e-05	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.06e-05	0.000276	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—H3F3A—malignant glioma	2.95e-05	0.000266	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCHE—malignant glioma	2.93e-05	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.92e-05	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PDGFB—malignant glioma	2.92e-05	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC5A5—malignant glioma	2.89e-05	0.00026	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.83e-05	0.000255	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH1—malignant glioma	2.81e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JAG1—malignant glioma	2.79e-05	0.000251	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CAV1—malignant glioma	2.76e-05	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.73e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.73e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FBXW7—malignant glioma	2.73e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SPHK1—malignant glioma	2.72e-05	0.000245	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.71e-05	0.000244	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2C18—malignant glioma	2.67e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—malignant glioma	2.67e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FN1—malignant glioma	2.63e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2—malignant glioma	2.63e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.59e-05	0.000233	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CG—malignant glioma	2.52e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.52e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTGS1—malignant glioma	2.5e-05	0.000225	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.49e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—EGF—malignant glioma	2.49e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PTPN11—malignant glioma	2.47e-05	0.000223	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.36e-05	0.000213	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—malignant glioma	2.33e-05	0.00021	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—malignant glioma	2.32e-05	0.000209	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT2—malignant glioma	2.3e-05	0.000207	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC5A5—malignant glioma	2.29e-05	0.000207	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.29e-05	0.000206	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	2.28e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAT—malignant glioma	2.27e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CD—malignant glioma	2.21e-05	0.000199	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.21e-05	0.000199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.17e-05	0.000195	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—malignant glioma	2.16e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NCOR1—malignant glioma	2.14e-05	0.000193	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN2B—malignant glioma	2.14e-05	0.000193	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HES1—malignant glioma	2.04e-05	0.000184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NCOR1—malignant glioma	2.03e-05	0.000183	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS1—malignant glioma	2.02e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.01e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAF1—malignant glioma	1.98e-05	0.000178	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PDGFRA—malignant glioma	1.94e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CB—malignant glioma	1.93e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—malignant glioma	1.88e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.88e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.86e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC5A5—malignant glioma	1.86e-05	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—malignant glioma	1.85e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAT—malignant glioma	1.8e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TERT—malignant glioma	1.79e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HLA-A—malignant glioma	1.79e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—malignant glioma	1.77e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.76e-05	0.000158	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PDGFB—malignant glioma	1.74e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAV1—malignant glioma	1.74e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.74e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGFR1—malignant glioma	1.74e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.71e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIF1A—malignant glioma	1.71e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NCOR1—malignant glioma	1.7e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.67e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CAV1—malignant glioma	1.65e-05	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CG—malignant glioma	1.59e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BAD—malignant glioma	1.55e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOTCH1—malignant glioma	1.54e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—malignant glioma	1.53e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.52e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD80—malignant glioma	1.51e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APC—malignant glioma	1.51e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—malignant glioma	1.51e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—malignant glioma	1.5e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGF—malignant glioma	1.49e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTPN11—malignant glioma	1.48e-05	0.000133	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAT—malignant glioma	1.46e-05	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BRAF—malignant glioma	1.42e-05	0.000127	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CD—malignant glioma	1.4e-05	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAV1—malignant glioma	1.38e-05	0.000125	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT2—malignant glioma	1.38e-05	0.000124	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NCOR1—malignant glioma	1.37e-05	0.000124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CD—malignant glioma	1.32e-05	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.32e-05	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KRAS—malignant glioma	1.28e-05	0.000115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF2—malignant glioma	1.27e-05	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CG—malignant glioma	1.26e-05	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CB—malignant glioma	1.22e-05	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—malignant glioma	1.22e-05	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—malignant glioma	1.21e-05	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MDM2—malignant glioma	1.19e-05	0.000107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RAF1—malignant glioma	1.18e-05	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CA—malignant glioma	1.18e-05	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—malignant glioma	1.17e-05	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CB—malignant glioma	1.15e-05	0.000104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—malignant glioma	1.14e-05	0.000102	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAV1—malignant glioma	1.12e-05	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CD—malignant glioma	1.11e-05	9.99e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.07e-05	9.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTEN—malignant glioma	1.05e-05	9.47e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CG—malignant glioma	1.02e-05	9.19e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTEN—malignant glioma	9.97e-06	8.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—malignant glioma	9.85e-06	8.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CB—malignant glioma	9.66e-06	8.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—malignant glioma	9.6e-06	8.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CD—malignant glioma	8.97e-06	8.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—malignant glioma	8.92e-06	8.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTEN—malignant glioma	8.35e-06	7.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—malignant glioma	8.29e-06	7.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—malignant glioma	8.1e-06	7.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CB—malignant glioma	7.82e-06	7.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—malignant glioma	7.75e-06	6.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KRAS—malignant glioma	7.66e-06	6.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CA—malignant glioma	7.42e-06	6.68e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CA—malignant glioma	7.03e-06	6.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTEN—malignant glioma	6.76e-06	6.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—malignant glioma	6.06e-06	5.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CA—malignant glioma	5.89e-06	5.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—malignant glioma	5.75e-06	5.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—malignant glioma	4.81e-06	4.33e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CA—malignant glioma	4.77e-06	4.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—malignant glioma	3.89e-06	3.51e-05	CbGpPWpGaD
